Bayer detailed plans for a $2.2 billion manufacturing site in New Albany, Ohio, projecting around 600 new jobs. The announcement adds to a broader set of US capacity moves by large pharma and could influence supply security for pipeline and commercial products depending on site scope and product allocation.